We provide you with 20 years of free, institutional-grade data for STOK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of STOK. Explore the full financial landscape of STOK stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-12 | 1623526 | STOK | 10-Q | Url |
| 2025-05-13 | 1623526 | STOK | 10-Q | Url |
| 2025-03-18 | 1623526 | STOK | 10-K | Url |
| 2024-11-05 | 1623526 | STOK | 10-Q | Url |
| 2024-08-07 | 1623526 | STOK | 10-Q | Url |
| 2024-05-06 | 1623526 | STOK | 10-Q | Url |
| 2024-03-25 | 1623526 | STOK | 10-K | Url |
| 2023-11-07 | 1623526 | STOK | 10-Q | Url |
| 2023-08-07 | 1623526 | STOK | 10-Q | Url |
| 2023-05-04 | 1623526 | STOK | 10-Q | Url |
| 2023-03-06 | 1623526 | STOK | 10-K | Url |
| 2022-11-14 | 1623526 | STOK | 10-Q | Url |
| 2022-08-08 | 1623526 | STOK | 10-Q | Url |
| 2022-05-10 | 1623526 | STOK | 10-Q | Url |
| 2022-03-10 | 1623526 | STOK | 10-K | Url |
| 2021-11-08 | 1623526 | STOK | 10-Q | Url |
| 2021-08-10 | 1623526 | STOK | 10-Q | Url |
| 2021-05-10 | 1623526 | STOK | 10-Q | Url |
| 2021-03-09 | 1623526 | STOK | 10-K | Url |
| 2020-11-12 | 1623526 | STOK | 10-Q | Url |
| 2020-08-10 | 1623526 | STOK | 10-Q | Url |
| 2020-05-15 | 1623526 | STOK | 10-Q | Url |
| 2020-03-23 | 1623526 | STOK | 10-K | Url |
| 2019-11-12 | 1623526 | STOK | 10-Q | Url |
| 2019-08-14 | 1623526 | STOK | 10-Q | Url |
| 2019-05-23 | 1623526 | STOK | S-1 | Url |
Stoke Therapeutics, Inc(NASDAQ:STOK) 
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary ribonucleic acid therapeutics platform, Targeted Augmentat...
Website: http://www.stoketherapeutics.com
Founded: 2015
IPO Price: $18 (Jun 19, 2019)
Full Time Employees: 56
CEO: Edward M. Kaye
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about STOK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.